Ananda Pharma PLC - Notice of Annual General Meeting

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU, WHICH IS PART OF UNITED KINGDOM DOMESTIC LAW PURSUANT TO THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS (SI 2019/310) ("UK MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION (AS DEFINED IN UK MAR) IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 30 July 2025

ANANDA PHARMA PLC 

("Ananda" or the "Company") 

Notice of Annual General Meeting

Ananda Pharma plc (AQSE: ANA, OTCQB: ANANF), a UK-based biopharmaceutical company developing regulatory approved, cannabidiol medicines to treat complex, chronic conditions, is pleased to announce that notice convening the Company's Annual General Meeting ("AGM") for 2.00pm BST on 26 August 2025 at the offices of Arch Law, Level 2, Huckletree, 8 Bishopsgate, London, EC2N 4BQ, has been sent to shareholders of the Company.

Full details of the resolutions proposed to the shareholders are available within the Notice of Meeting, available at https://investors.anandapharma.co.uk/s/0e221d under the Notices and Meetings tab.

Melissa Sturgess will be giving a corporate update presentation and Q&A session via the Company's InvestorHub on 12^th of August 2025 at 12.00pm.

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via the webinar page up until 12.00pm on 11^th of August 2025, or at anytime during the live presentation.

Investors can sign up to the webinar for free via: https://investors.anandapharma.co.uk/s/09bdfb.

About Ananda Pharma

Ananda Pharma (AQSE: ANA) is a UK-based biopharmaceutical company developing regulatory approved, cannabidiol medicines to treat complex, chronic conditions, including epilepsy (trials funded by NHS England and NIHR), endometriosis (funded by NHS Scotland) and chemotherapy pain (funded by NIHR).  The Company is led by successful entrepreneurs and is working with a team of world-class scientists, including globally respected Key Opinion Leaders at the University of Edinburgh, Great Ormond Street Hospital for Children and University College London.

For more information, please visit our website:

To stay up to date with Ananda's news please follow our social media channels:  

·              Investor Hub: https://investors.anandapharma.co.uk/s/ea8f93

·              Instagram: https://www.instagram.com/anandapharmaplc/

·              LinkedIn:  https://www.linkedin.com/company/anandapharma

·              X: https://twitter.com/AnandaPlc

·              Investor Meet Company: https://www.investormeetcompany.com/ananda-pharma-plc/register-investor

-Ends-

For the purposes of UK MAR, the Directors of the Company accept responsibility for the contents of this announcement.  

https://investors.anandapharma.co.uk/link/y05zke